Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
4.650
-0.010 (-0.21%)
Nov 21, 2024, 2:29 PM EST - Market open
Relay Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -345.2 | -341.97 | -290.51 | -363.87 | -52.41 | -75.31 | Upgrade
|
| Depreciation & Amortization | 5.51 | 5.27 | 4.13 | 3.93 | 3.55 | 2.85 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.06 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 123 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -13.8 | -10.76 | 1.18 | 13.91 | -0.42 | -2.5 | Upgrade
|
| Stock-Based Compensation | 95.77 | 86.03 | 56.14 | 48.45 | 31.96 | 4.46 | Upgrade
|
| Other Operating Activities | -15.27 | -6.42 | -11.68 | 2.84 | - | - | Upgrade
|
| Change in Accounts Receivable | 0.21 | 5.22 | -0.28 | 77.79 | -82.65 | - | Upgrade
|
| Change in Accounts Payable | -6.37 | -2.39 | 1.99 | 0.93 | -0.41 | 3 | Upgrade
|
| Change in Unearned Revenue | -0.02 | - | -0.25 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -1.25 | -35.28 | 9.78 | 18.62 | -2.11 | 1.31 | Upgrade
|
| Operating Cash Flow | -280.43 | -300.32 | -229.49 | -74.41 | -102.49 | -66.13 | Upgrade
|
| Capital Expenditures | -2.14 | -4.13 | -9.06 | -3.47 | -1.93 | -8 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.02 | Upgrade
|
| Cash Acquisitions | - | - | - | -25.3 | - | - | Upgrade
|
| Investment in Securities | -8.27 | 261.76 | -179.68 | -450.74 | 83.6 | -311.04 | Upgrade
|
| Investing Cash Flow | -10.4 | 257.63 | -188.75 | -479.51 | 81.67 | -319.02 | Upgrade
|
| Issuance of Common Stock | 291.27 | 34.75 | 289.91 | 388.09 | 426.51 | 0.61 | Upgrade
|
| Financing Cash Flow | 291.27 | 34.75 | 289.91 | 388.09 | 426.51 | 5.61 | Upgrade
|
| Net Cash Flow | 0.44 | -7.93 | -128.33 | -165.83 | 405.69 | -379.55 | Upgrade
|
| Free Cash Flow | -282.56 | -304.44 | -238.55 | -77.88 | -104.42 | -74.14 | Upgrade
|
| Free Cash Flow Margin | -2823.94% | -1191.74% | -17273.86% | -2571.05% | -126.33% | - | Upgrade
|
| Free Cash Flow Per Share | -2.14 | -2.48 | -2.13 | -0.82 | -2.45 | -21.49 | Upgrade
|
| Levered Free Cash Flow | -156.57 | -183.52 | -108.6 | -8.17 | -87.24 | -51.3 | Upgrade
|
| Unlevered Free Cash Flow | -156.57 | -183.52 | -108.6 | -8.17 | -87.24 | -51.3 | Upgrade
|
| Change in Net Working Capital | 8.86 | 33.56 | -34.54 | -84.24 | 85.95 | -1.93 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.